Library: Policy

340:100-5-26.1. Psychotropic medication

Revised 9-15-23

(a) Oklahoma Administrative Code (OAC) 340:100-5-26.1 applies to service recipients receiving:

(1) community residential supports per OAC 340:100-5-22.1;

(2) group home services per OAC 340:100-6; or

(3) behavioral supports in Level D group homes.

(b) A psychotropic medication is a drug used to treat a mental disorder or any drug prescribed to stabilize or improve mood, mental status, or behavior per OAC 340:100-1-2.

(c) Medication is not used as punishment, for staff's convenience, as a substitute for a program, or in quantities that interfere with a service recipient's participation in programming.

(d) The service recipient's Personal Support Team (Team) obtains a description of data to be collected to evaluate the psychotropic medication's effectiveness, from the prescribing healthcare provider.

(1) The Team:

(A) identifies a method for collecting necessary data; and

(B) specifies a routine method for reporting this data to the prescribing healthcare provider.

(2) When psychotropic medication is changed, the Team obtains new instructions for additional or different data needed to evaluate the effectiveness of the new medication, from the prescribing healthcare provider.

(e) The Team monitors for side effects, such as tardive dyskinesia per OAC 340:100-5-29.

(f) The Team reviews the use of psychotropic medication annually during the individual planning process per OAC 340:100-5-53.

(g) The Team must develop a protective intervention protocol per OAC 340:100-5-57 to address behavioral symptoms being treated by the psychotropic medication.

(h) Developmental Disabilities Services (DDS) defines the use of p.r.n. medication for behavioral control to be a highly-restrictive procedure per OAC 340:100-3-34. Medication is considered for behavioral control when it is prescribed to achieve a desired behavioral outcome. When a medication is ordered to be administered p.r.n. for behavioral control:

(1) the Team:

(A) ensures there is a specific, written protocol for the administration of the p.r.n. medication from the prescribing healthcare provider as part of a protective intervention protocol per OAC 340:100-5-57;

(B) notifies the DDS director of pharmacy services and requests a pharmacy review within five-business days; and

(2) the contract provider agency staff follows critical incident reporting requirements per OAC 340:100-3-34.